Investigational OCTA Devices Show Promise in Diabetic Disease Assessment - Top-Institutions - MDSpire

Investigational OCTA Devices Show Promise in Diabetic Disease Assessment

At Retina World Congress, Patricio G. Schlottmann, MD, discussed investigational widefield OCTA platforms made by Chinese company TowardPi Medical.

  • By

  • Patricio G. Schlottmann, MD

  • Patricio G. Schlottmann, MD

  • May 14, 2026

  • 2 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, Florida

    Key Differentiators

    • Ophthalmology

  • #2

    Wilmer Eye Institute
    Wilmer Eye Institute

    Baltimore, Maryland

    Key Differentiators

    • Ophthalmology

Original Source(s)

Investigational OCTA Devices Show Promise in Diabetic Disease Assessment

  • by Patricio G. Schlottmann, MD, Patricio G. Schlottmann, MD

  • May 14, 2026

Related Content

New Strategies for Managing Diabetic Retinopathy

California considers seal of approval for foods that are not ultra-processed

Suprachoroidal Injection in the Treatment of Diabetic Macular Edema: Mechanisms, Clinical Advances, and Future Perspectives